JPS5965010A - Capsule for oily of fatty suppository - Google Patents

Capsule for oily of fatty suppository

Info

Publication number
JPS5965010A
JPS5965010A JP17476382A JP17476382A JPS5965010A JP S5965010 A JPS5965010 A JP S5965010A JP 17476382 A JP17476382 A JP 17476382A JP 17476382 A JP17476382 A JP 17476382A JP S5965010 A JPS5965010 A JP S5965010A
Authority
JP
Japan
Prior art keywords
base material
drug
capsule
planing
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17476382A
Other languages
Japanese (ja)
Inventor
Mitsuo Matsumoto
光雄 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP17476382A priority Critical patent/JPS5965010A/en
Publication of JPS5965010A publication Critical patent/JPS5965010A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PURPOSE:A capsule for oily of fatty suppositories, consisting of a hollow shell, molded from an oily or fatty base material for the suppositories, and capable of filling the hollow part with a drug, and having reduced undesirable change in the base material caused by the mixing with the drug, etc. CONSTITUTION:A capsule for suppositories consisting of a hollow shell, molded from an oily or fatty base material, e.g. cacao butter, and capable of filling the hollow part with a drug 4. Preferably, the above-mentioned hollow shell 1 is constituted of a spindle-, torpedo- or cannonball-shaped body 2 having one opened end and a plug 3 for sealing up the above-mentioned opening. The use of the above-mentioned capsule will not cause the undesirable change in the physical properties of the base material due to the mixing with the drug, and the base material can be easily selected. Furthermore, the capsule has many advantages as follows: The previously mass produced capsules provide the preparation of aimed suppositories only by filling the hollow part with various drugs if necessary, and the drug is not deteriorated by warming, etc.

Description

【発明の詳細な説明】 本発明は、その内部に医薬品を充填して平削を調製りる
ことがCぎる中空の油脂性平削用力ブレルに関りるらの
である。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a hollow oleaginous planing barrel whose interior can be filled with pharmaceuticals to prepare planing.

平削は医薬品の投与法として古くから用いられてきたし
のであり、近時、投与後の吸収、薬物代謝零の見地から
、肛門等局所の治療のみでなく、鎮痛剤、抗生物質等全
身治療を目的とする医薬品の投!ゴ法としても注目され
ている。
Planing has long been used as a method of administering pharmaceuticals, and recently, from the standpoint of post-administration absorption and zero drug metabolism, it has been used not only for local treatment such as the anus, but also for systemic treatment such as analgesics and antibiotics. Throwing the desired medicine! It is also attracting attention as a law.

現在心胆に段ちする平削は次の3種に大別され、最も広
く用いられるのは油脂性平削である。
Currently, the most common types of planing are divided into the following three types, with oil-based planing being the most widely used.

これ以外に油脂性平削と同様にマクロゴールのような常
温固形の水溶性物質にIX W4品を加えた水溶性゛平
削があるが刺激性などの欠点がある。1第3の平削とし
て内部の医薬品油性溶液または油性懸濁液をゼラチン被
包で包む経口用の軟カプセルと同様の方法で作られる心
胆用カブレルと称されるものがある。しかしこのものは
、被包が水溶性のLラチンであるため内部に入れ得る薬
品は油性のものか、油性溶液か油14fiiTi液に限
られること、直腸挿入部に肛門括約筋の力に抗するため
に、内部が空間がなく完全に充満されていること、挿入
しヤlTlい形にづ゛ることが製法上困難なこと、強度
をあげるためLラチン膜を厚く覆ると直腸内で崩壊しが
たくなること等から、実際の製剤化には制約が多い。ま
た、ゼラチン被包の表面は滑りが悪く狛に吸湿りるとこ
れが著しく使用が困難である。
In addition to this, there is water-soluble planing, which is made by adding IXW4 to a water-soluble substance that is solid at room temperature, such as macrogol, similar to oil-based planing, but it has drawbacks such as irritation. 1. As a third type of planing, there is a product called cardiac cabrel made in the same manner as oral soft capsules in which the internal pharmaceutical oil-based solution or oil-based suspension is wrapped in gelatin encapsulation. However, since the capsule of this product is water-soluble L-latin, the chemicals that can be put inside are limited to oil-based ones, oil-based solutions, or oil-14fiiTi fluids, and the rectal insertion site has to resist the force of the anal sphincter muscle. The main reason for this is that the inside is completely filled with no space, that it is difficult due to the manufacturing process to maintain the correct shape when inserted, and that if the L-latin membrane is thickly covered to increase strength, it will not disintegrate in the rectum. There are many restrictions on actual formulation due to the fact that it makes people want to eat it. Furthermore, the surface of the gelatin encapsulation is not slippery and if it absorbs moisture, it is extremely difficult to use.

現在用いられCいる油脂性平削は、平削の油脂1j1.
7S!剤物′?!1ど1ス話品とを均一に混合した混合
物を、通常i¥8〜121IIIIl、良さ30〜40
Il1g11容偵3・〜・3.;目11.+1、車1n
3−iPi!度の紡錘形、魚雷形、ししくは砲弾形に成
形したものである。
The oil-based planing currently used is oil-based planing 1j1.
7S! Drug'? ! A mixture of 1 and 1 souvenirs is mixed uniformly, usually ¥8-121, quality 30-40
Il1g11 detective 3...3. ;Eye 11. +1, car 1n
3-iPi! It is shaped like a spindle, a torpedo, or a cannonball.

油脂性基剤物質としては、カカオ脂、ラウリン脂性1本
温e融解する天然油脂類が一般に用いられCいるが、近
年、種々の油脂に水素添加しC適当な融点をもたせた硬
化油脂類も使用されている。また、硬さや成形性等の点
から、これらの油脂f1に適当な油脂酸ジグリセライド
やモノグリレライド等を加えることもなされている。
As the oil-based base material, cacao butter and lauric oil-based natural oils and fats that melt at temperature are generally used, but in recent years, hydrogenated oils and fats that have been hydrogenated to various oils and fats have also been used. It is used. In addition, from the viewpoint of hardness, moldability, etc., appropriate fat acid diglyceride, monoglyceride, etc. are added to these fats and oils f1.

通常はこれら油脂性基剤物質を加温融解し、これにtZ
 *V品を211 W?さUるかあるいは粉末のまま均
一に分散させたのち、成形型に流し込み、冷7.11後
望から取り出J方法により平削が!!7aされでいる。
Usually, these oily base materials are heated and melted, and then tZ
*V product at 211W? After uniformly dispersing it as a powder, pour it into a mold, take it out from the cold after cooling, and plan it using the J method! ! 7a has been completed.

このJ、うにしく得られた平削は、常温にJ3いて肛門
に挿入できる適当な硬度を有している必要があり、同時
に肛門内の体温で融解する必要がある1、このため配合
づる医薬品と基剤物質との相互関係が重要となり、基剤
物質単独では冷却固化したときに適当な強度をイコしか
つ望J、しい体温融解を示づものでも、医薬品と)配合
されるど固化の状況が変化し、特にでの硬瓜おにび温痩
上胃時の融解状況が製造時あるい(よその後の保存JU
J間中に著しく変化覆ることがあり、平削としての有効
性を期待し得ない場合が生じる。
The obtained planed material needs to have an appropriate hardness to be inserted into the anus at room temperature, and at the same time it needs to melt at the body temperature inside the anus. The interaction between the base material and the base material is important, and even if the base material alone exhibits appropriate strength and desirable body temperature melting when solidified by cooling, it may not be possible to solidify when combined with a drug. Circumstances change, especially the thawing state of hard melons during production (and subsequent storage).
There may be significant changes during the J process, and the effectiveness of planing cannot be expected.

これを防ぐために、種々の基剤物f1を配合したり、(
の他の融解剤等の添加物を加える必要が生じる。
In order to prevent this, various base materials f1 are blended, (
It becomes necessary to add additives such as other melting agents.

また、医薬品を油脂性基剤物質と混合づる際、医薬品が
不溶解性のものであると、成形型に注入後固化づるまで
に、混合した医薬品が沈降し、先端部に集合覆る場合が
ある。また、基剤物質と加温時均−に溶解混合づる医薬
品で゛b、製造後の保存中に平削中で医薬品の結晶が析
出、成長し、これに伴い製剤が脆化りる現象も生じるこ
とがある。
Additionally, when mixing pharmaceuticals with oil-based base materials, if the pharmaceuticals are insoluble, the mixed pharmaceuticals may settle and collect at the tip after being injected into the mold and before solidifying. . In addition, for pharmaceuticals that are dissolved and mixed with the base material over a uniform heating time, crystals of the pharmaceutical may precipitate and grow during planing during storage after manufacture, resulting in embrittlement of the drug product. This may occur.

さらには、熱により分解、失活りる医薬品は上記のごと
き融解法では製造することができず、そのIこめ、油脂
性基剤物質と医薬品との混合物を冷時に圧縮成形づる方
法も行なわれているが、特定の医薬品へ除いCは、油脂
性の基剤物質との均一な混合(、i内列である1゜ −ぞこで本発明化は、上述したごとき従来の平削に、1
5いてみられる@薬品と基剤物質どの相互関係に起因(
る種々の欠点を解消できる平削を提供Jることを目的と
しで111究を重ねた結果、平削の油脂性基剤物質のみ
で予め中空殻体を成形しくc13さ、この殻体中空部に
医薬品を充填Jることに、J、す、上記の目的を達成で
きることを児出し本発明を完成させたものである。
Furthermore, pharmaceuticals that are decomposed and deactivated by heat cannot be manufactured by the above-mentioned melting method, and another method is also used in which a mixture of an oily base material and a pharmaceutical is compression molded while cold. However, except for certain pharmaceutical products, C is uniformly mixed with an oil-based base material (i). 1
5 Due to the interaction between the drug and the base material (
As a result of 111 studies aimed at providing a planing method that can eliminate the various drawbacks of planing, it was possible to form a hollow shell in advance using only an oil-based base material for planing, and the hollow part of this shell was The present invention has been completed by discovering that the above objects can be achieved by filling the container with pharmaceuticals.

以下に図面に示す好ましい実施例を参照して本発明を詳
述りる。
The invention will be explained in detail below with reference to preferred embodiments shown in the drawings.

第1図は、本発明の油脂性平削用カプレルどしC使用さ
れる中空殻体1の断面図であり、一端が聞1−11.た
砲弾形の本体2と、開口を密封するための栓3とから構
成されている。これら殻体本体2および栓3の材質どし
ては、平削の油脂性基剤物質として従来から慣用されて
いる物質、例えばカカオ脂、ラウリン脂等の天然油脂類
や各種硬化油脂類、さらに(Jこれら油脂類に脂肪酸ジ
グリセライドや七ノグリヒライド等を添加したbの等が
使用でき・る。
FIG. 1 is a cross-sectional view of a hollow shell 1 used in the oil-based planing coupler C of the present invention, with one end extending from 1-11. It consists of a bullet-shaped main body 2 and a plug 3 for sealing the opening. The shell main body 2 and the plug 3 may be made of materials conventionally used as oil-based base materials for planing, such as natural oils and fats such as cacao butter and lauric butter, various hydrogenated oils and fats, and (J) These fats and oils can be used with addition of fatty acid diglyceride, 7-glyceride, etc.

また中空殻体の厚さは、1匁薬品を充填づるために十分
な中空部容積をりえ、かつ平削ど1ノ゛Cの取扱いや強
度の確保に十分な厚さを適宜選択すればJ、く、一般的
には頭頂部は約5mm、側部は約1.5〜2mm程度の
厚さとし、中空部には約500n1g Vi度の粉末医
薬品を充填できるJ、うに〜Jることが望ましい。
In addition, the thickness of the hollow shell should be appropriately selected to have a sufficient hollow volume to fill 1 monme of the drug, and a thickness sufficient to ensure handling and strength of 1 mm for planing. In general, the top of the head should be about 5 mm thick, the sides should be about 1.5 to 2 mm thick, and the hollow part should preferably be filled with about 500 g of powdered medicine of Vi degree. .

なJj図示の例では中空殻体の形状を砲弾形と1ノでい
るが、紡錘形や魚雷形等の平削として9.fましい形状
であれば、その形状は!l!1に限定されない。
In the illustrated example, the shape of the hollow shell is a cannonball shape, but it can also be planed into a spindle shape, torpedo shape, etc. If the shape is frightening, then the shape is! l! It is not limited to 1.

中空殻体の本体263 J、σ栓3は、【壜1ぞれの形
状に対応した成形型を用い、加温融解せしめた油脂性基
剤物質をこの成形型に流し込み、これを冷却固化された
のち型から取り出すことによって容易に製造り°ること
がでさる、。
The main body 263 J of the hollow shell body and the σ stopper 3 are made by [Using a mold corresponding to the shape of each bottle, heated and melted oleaginous base material is poured into the mold, and this is cooled and solidified. It can be easily manufactured by removing it from the mold afterwards.

第2図は、本発明の油脂性平削用カプセルを用いて製造
しlζ坐平削断面図であり、第1図の殻体本体2内の中
空部に1久薬品4を充填したの15、聞1−1部を栓3
で密封したものである。充填刀る医薬品は粉末、溶液ま
たは懸濁液等のいかなる状態のらのです、J、い。密封
に際しては、栓3の表面を加湿して融解させておき本体
2の聞白部に圧着すれば、冷却後両者は確実に密着し、
内容物が洩れ出るa3それはない。
FIG. 2 is a planing cross-sectional view of a lζ sitting capsule manufactured using the oil-based planing capsule of the present invention. , 1-1 parts with stopper 3
It is sealed. Filled medicines can be in any form such as powder, solution or suspension. When sealing, if the surface of the stopper 3 is moistened and melted and then crimped onto the white part of the main body 2, the two will surely come into close contact after cooling.
A3 There is no possibility that the contents will leak out.

ト述したごとき本発明の油脂性平削用カプセルを用いる
ことによって、基剤物質と医薬品とを混合せずに平削を
製造できるから、医薬品を混合することによる基剤物質
の好ましくない物性変化をもたらすことがない。従2て
、医薬品の種類に関係なく油脂性基剤物質のみの直腸内
での融解状態を考慮して最も適した油脂性基剤物質を選
択りればよい。また、保存中の強度や融解状態の変化に
ついてら、基剤物質となる油脂類のみの物7゛1につい
て考慮すればよい。
By using the oleaginous planing capsule of the present invention as described above, planing can be produced without mixing the base material and the drug, so that undesirable changes in physical properties of the base material due to mixing the drug can be avoided. It never brings. Therefore, regardless of the type of drug, the most suitable oleaginous base material may be selected by considering the melting state of only the oleaginous base material in the rectum. In addition, with regard to changes in strength and melting state during storage, consideration should be given to the product 7゛1 containing only fats and oils as the base material.

さらには、予め本発明の油脂性平削用カプセルを量産し
ておりば、これに種々の医薬品を必要に応じて充填Jる
だ番ノC平削を製32iづることができ、まlζ、医薬
品の充填前にfJ加渇土稈を施づ必要がないから、医薬
品の加温にJ、る品!1゛j劣化をもたらすおそれもな
い。
Furthermore, if the oil-based planed capsules of the present invention are mass-produced in advance, it is possible to fill them with various pharmaceuticals as needed and make the planed capsules. Since there is no need to apply fJ heating and cooling before filling medicines, it is a great product for heating medicines! 1゛j There is no risk of causing deterioration.

また、本発明の油脂性平削用力ブレルは、従来のゼラチ
ンを用いた直腸用カプセルとは胃なり、油脂性基剤物質
を用いているからこれ、J:での油脂性平削と同様に容
易に挿入でき、また内部に充填する医薬品も粉末、FB
 ’dシ、懸渇′a等のいずれでもよく、常温で基剤物
質の殻体を溶解しく2い水溶液として医薬品を充1fI
づ°ることしiil能である。さらに、心胆粘膜からの
吸収を促進さけるための補助剤を配合−7Iる際にし、
補助剤を基剤物質中に分散させることなく医薬品中に配
合覆ればよいから、基剤物質中に補助剤を分散させてい
た従来の場合に比へてJ、り有効Cある。また、持続1
4を付与するJ、うに加Tされた配合医薬品粉末を充填
すれば、平削に持続性をもたせることも可能となる。
In addition, the oleaginous planing capsule of the present invention is different from the conventional rectal capsule using gelatin, and since it uses an oleaginous base material, it is similar to the oleaginous planing in J:. It can be easily inserted, and the medicines filled inside can be powdered or FB.
Either 'd' or 'd'a may be used, and the drug is filled with the drug as a dilute aqueous solution that dissolves the shell of the base material at room temperature.
It's all about ability. Furthermore, when adding adjuvants to promote absorption from the cardiobiliary mucosa,
Since the auxiliary agent can be incorporated into the drug without being dispersed in the base material, it is more effective than the conventional case in which the auxiliary agent is dispersed in the base material. Also, duration 1
If the powder is filled with a blended pharmaceutical powder that has been added with J and T, it is possible to make the planing process more sustainable.

以十に本発明の実施例rFjよび参考例を挙げ−(さら
に説明づる。
Hereinafter, examples rFj and reference examples of the present invention will be listed (further explanation will be provided).

実施例1゜ F) OT;でfll解させたカカオ脂を成形型に流し
込み、20 ”Ctこ冷141シたの15型から取り出
して、第′I図に小しIごごとき砲弾形の中空殻体(本
体外形の高さ35 a+m、外径101nn+;中空部
の高さ301nIn、内i’(Ir 、 5 III 
nl :頭頂部厚さ5mm、側部厚さ 1 、75 m
 m  H栓の厚さ5mm)を製造した。
Example 1 ゜F) Cocoa butter melted completely at OT was poured into a mold and taken out from a 20" Ct cold 141 sheet mold 15. Shell (main body external height 35 a + m, outer diameter 101 nn +; hollow part height 301 nIn, inner i' (Ir, 5 III
nl: Top thickness 5mm, side thickness 1,75m
m H plug thickness 5 mm) was manufactured.

参考1<411 。Reference 1<411.

I−i’i+!実施例1でir:Iられた中空殻体の本
体中空部に100mりのインドメザシン粉末を充填した
の15、聞[1部を栓により密封し、イントメ4)−シ
ン1剤を調製し1.:a 実施例2゜ 水添植物油に脂肪酸モノグリレライドを添加した基剤物
質[ライテップゾール H15J(CI+a+n1Sc
l+c  Werke  Witten社(西ドイツ製
商品名)を50℃で融解し、成形型に流し込み、20°
0に冷ujシたのち型から取り出して、実施例1と同じ
形状、寸法の中空殻体を製造しIこ 。
I-i'i+! 100 m of indomezacin powder was filled into the hollow part of the main body of the hollow shell body subjected to ir:I in Example 1, and 1 part was sealed with a stopper to prepare 1 drug of indomezacin. :a Example 2 Base material obtained by adding fatty acid monoglyrelide to hydrogenated vegetable oil [Litepsol H15J (CI+a+n1Sc)
l+c Werke Witten (product name made in West Germany) was melted at 50°C, poured into a mold, and heated at 20°C.
After cooling to zero, it was removed from the mold to produce a hollow shell having the same shape and dimensions as in Example 1.

参考例2゜ 上記実施例2′C・得られた中空殻体の本体中空部に1
リス[Jマイシン粉末1 !i 0 Hlりを充j眞1
)たのち、開[1部を栓にJ、り密封(〕、エリスIJ
ン、イシン坐剤を調製した。
Reference Example 2゜Above Example 2'C・1 in the hollow part of the main body of the hollow shell obtained
Squirrel [J Mycin Powder 1! i 0 Hl fill up jshin 1
), then open [1 part with stopper J, and seal (], Ellis IJ
Ishin suppositories were prepared.

参考例3゜ 上記実施例2で19られだ中空殻体の本体中空部にロー
ト1キスを5倍吊の水で希釈1ノたJili 1fJ液
を0 、5 m、Q充1i 1.たのち、l1tl l
’、’1部/、、、 1′、xにJ、、 ’)で密14
シ、ロー1〜エキス坐剤を調製した。
Reference Example 3゜In the hollow part of the main body of the 19 hollow shell body obtained in Example 2 above, one drop of the Jili 1fJ solution diluted with 5 times the amount of water was poured into the hollow part of the hollow shell body at 0.5 m, Q filled 1i 1. Later, l1tl l
', '1 part/,,, 1', x for J,, ') is dense 14
Extract suppositories were prepared.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の油脂竹平削用マイク1−1カシセルの
好ましい実施例を示す断面図(あり、第2図は第1図の
油脂性平削用マイクr、+ )J −、/’ しニルに
医薬品を充1眞して:A製した平削を示’J’ l1J
i而図である。 1・・・中空殻体、2・・・本体、3・・・栓、4・・
・医訃品。 第1図 第2図
FIG. 1 is a cross-sectional view showing a preferred embodiment of the oil-and-fat bamboo planing microphone 1-1 according to the present invention. Fill the pot with medicine and show the planing made by A 'J' l1J
This is a diagram. 1...Hollow shell, 2...Main body, 3...Bung, 4...
・Medical products. Figure 1 Figure 2

Claims (1)

【特許請求の範囲】 1、平削の油脂性基剤物質で成形した中空殻体から4劣
り、その中空部に医薬品を充填できるように1ノだ油脂
性平削用カプレル。 2、前記中空殻体は、一端が間口した紡錘形、魚雷形J
:たは砲弾形の本体と該開口を密封づる栓とからなって
いる特許請求の範囲第1項記載の油flit M平削用
カプセル。
[Scope of Claims] 1. An oil-based planing capler having a hollow shell formed from a planing oil-based base material and having a diameter of 1 hole so that the hollow portion can be filled with pharmaceuticals. 2. The hollow shell has a spindle shape with a frontage at one end, and a torpedo shape J
The oil flit M planing capsule according to claim 1, comprising a shell-shaped main body and a plug for sealing the opening.
JP17476382A 1982-10-05 1982-10-05 Capsule for oily of fatty suppository Pending JPS5965010A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17476382A JPS5965010A (en) 1982-10-05 1982-10-05 Capsule for oily of fatty suppository

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17476382A JPS5965010A (en) 1982-10-05 1982-10-05 Capsule for oily of fatty suppository

Publications (1)

Publication Number Publication Date
JPS5965010A true JPS5965010A (en) 1984-04-13

Family

ID=15984238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17476382A Pending JPS5965010A (en) 1982-10-05 1982-10-05 Capsule for oily of fatty suppository

Country Status (1)

Country Link
JP (1) JPS5965010A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0435328U (en) * 1990-07-20 1992-03-24
JPH04187636A (en) * 1990-11-20 1992-07-06 Isamu Horikoshi Narcotic preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0435328U (en) * 1990-07-20 1992-03-24
JPH04187636A (en) * 1990-11-20 1992-07-06 Isamu Horikoshi Narcotic preparation

Similar Documents

Publication Publication Date Title
DE3626362C2 (en) Delivery device for releasing an active ingredient to ruminants
RU2134105C1 (en) Soft gelatine capsule
DE3634864A1 (en) DELIVERY DEVICE FOR RELEASING A TEMPERATURE-RELEVANT MEASURE
DE3626415A1 (en) VETERINA MEDICAL DISPENSER
JPH0333338B2 (en)
JPS62114911A (en) Oral administration type slow release medicine
DE3625915A1 (en) DELIVERING DEVICE FOR RELEASING AN ACTIVE SUBSTANCE
KR20000022433A (en) Lubrication assistant and process for the preparation of ethyl stearate used therein
US3440320A (en) Chelated suppository and method of using same
JPH07502763A (en) Confectionery-like delivery system for pharmaceutical active substances
JPH0565222A (en) Film containing pullulan blended therein for capsule and capsule
US1356544A (en) Medicinal effervescing capsule
KR100446118B1 (en) Process for the manufacture of liquid filled capsules
JPS5965010A (en) Capsule for oily of fatty suppository
US4397835A (en) Enterosoluble hard-capsulated medicaments
US2055063A (en) Suppository medication
JPS638327A (en) Molding comprising pellet
JPS58121210A (en) Manufacture of instantaneous mouth discharging sublingual soft capsule medicine
US251355A (en) Edwin h
JPH0639374B2 (en) Effervescent glycerin suppository
US2196283A (en) Capsule
JPS601281B2 (en) suppositories
DE145918C (en)
WO1995008321A1 (en) A capsule for delivering drugs into cattle stomachs
RU2038075C1 (en) Method for manufacturing suppository